Glenn D Fogel sold $2.6M of BKNG
CEO AND PRESIDENT at Booking Holdings Inc.. 750 shares at an average of $3,493.71, traded Jan 16, 2024, filed Jan 17, 2024.
Score components
- +25RoleCEO
- +25Trade size$2.6M at market
- 0Share of holdings soldSold 2.1% of holdings
- +15Cluster3 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-24-001295, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 16, 2024 | SOpen-market sale Common Stock10b5-1 | -37 | $3,467.67 | $128k | 35,601 | Jan 17, 2024 |
| Jan 16, 2024 | SOpen-market sale Common Stock10b5-1 | -37 | $3,476.64 | $129k | 35,564 | Jan 17, 2024 |
| Jan 16, 2024 | SOpen-market sale Common Stock10b5-1 | -37 | $3,483.18 | $129k | 35,527 | Jan 17, 2024 |
| Jan 16, 2024 | SOpen-market sale Common Stock10b5-1 | -37 | $3,484.72 | $129k | 35,490 | Jan 17, 2024 |
| Jan 16, 2024 | SOpen-market sale Common Stock10b5-1 | -37 | $3,485.73 | $129k | 35,453 | Jan 17, 2024 |
| Jan 16, 2024 | SOpen-market sale Common Stock10b5-1 | -37 | $3,487.76 | $129k | 35,416 | Jan 17, 2024 |
| Jan 16, 2024 | SOpen-market sale Common Stock10b5-1 | -37 | $3,491.28 | $129k | 35,379 | Jan 17, 2024 |
| Jan 16, 2024 | SOpen-market sale Common Stock10b5-1 | -37 | $3,493.31 | $129k | 35,342 | Jan 17, 2024 |
| Jan 16, 2024 | SOpen-market sale Common Stock10b5-1 | -111 | $3,496.64 | $388k | 35,231 | Jan 17, 2024 |
| Jan 16, 2024 | SOpen-market sale Common Stock10b5-1 | -74 | $3,498.32 | $259k | 35,157 | Jan 17, 2024 |
| Jan 16, 2024 | SOpen-market sale Common Stock10b5-1 | -74 | $3,499.41 | $259k | 35,083 | Jan 17, 2024 |
| Jan 16, 2024 | SOpen-market sale Common Stock10b5-1 | -74 | $3,502.17 | $259k | 35,009 | Jan 17, 2024 |
| Jan 16, 2024 | SOpen-market sale Common Stock10b5-1 | -74 | $3,503.43 | $259k | 34,935 | Jan 17, 2024 |
| Jan 16, 2024 | SOpen-market sale Common Stock10b5-1 | -47 | $3,504.49 | $165k | 34,888 | Jan 17, 2024 |
Related signals
Other insiders at Booking Holdings Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 16Weak | Booking Holdings Inc. | Paulo Pisano CHIEF HUMAN RESOURCES OFFICER | $260k 1,500 shares | -2% | |
| 15Weak | Booking Holdings Inc. | Robert J Mylod Jr director | $200k 1,000 shares | -7% | |
| 30Weak | Booking Holdings Inc. | Paulo Pisano CHIEF HUMAN RESOURCES OFFICER | $610k 3,000 shares | -4% | |
| 40Moderate | Booking Holdings Inc. | Peter J Millones EXECUTIVE VP, GENERAL COUNSEL | $10M 50,050 shares | -12% | |
| 19Weak | Booking Holdings Inc. | Vanessa Ames Wittman director | $79k 375 shares | -2% | |
| 52Moderate | Booking Holdings Inc. | Ewout L Steenbergen CHIEF FINANCIAL OFFICER | $4.2M 20,000 shares | -25% | |
| 22Weak | Booking Holdings Inc. | Robert J Mylod Jr director | $207k 1,000 shares | -6% | |
| 40Moderate | Booking Holdings Inc. | Robert J Mylod Jr director | $1.0M 5,000 shares | -24% | |
| 15Weak | Booking Holdings Inc. | Vanessa Ames Wittman director | $216k 1,125 shares | -6% | |
| 25Weak | Booking Holdings Inc. | Peter J Millones EXECUTIVE VP, GENERAL COUNSEL | $10M 62,500 shares | -13% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.